Eric Singhi, Thoracic Medical Oncologist and Assistant Professor at MD Anderson Cancer Center, shared a post on X:
“Kicking off PRIMONYLung25 with a EGFR+ NSCLC talk by Christine Garcia.
Great questions by the audience:
- What to do if uncommon EGFR mutations in resectable dz?
- How to choose between FLAURA2 and MARIPOSA?
- Why less impressive response with NEOADAURA chemotherapy plus osi v FLAURA2 in mNSCLC?”
More posts featuring PRIMONYLung25.